OMRON Corp
6645: XTKS (JPN)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|&n | LOCK|nfG!v | LOCK|rydY#jnz |
Omron Earnings: Profit Miss as HCB Drags; 22% Cut in Our Fair Value Reflects Long-Term Shift
Omron's June-quarter sales rose 3.1% year on year, with the operating margin at 3.4%. Industrial automation grew 10.5% yearly, offsetting a 17.9% yearly decline in healthcare, or HCB. The company maintained its fiscal 2025 (ending March 2026) sales growth guidance of 2.3%-4.1%.
